Stereotactic brachytherapy of low-grade cerebral glioma after tumor resection

Neuro-Oncology

Volumn 13, Issue 10, 2011, Pages 1133-1142

  Suchorska, Bogdana ^a   Ruge, Maximilian ^b   Treuer, Harald ^b   Sturm, Volker ^b   Voges, Jürgen ^c  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

125 iodine seeds; Brachytherapy; Low grade glioma; Resection; Stereotaxy

Indexed keywords

ANTINEOPLASTIC AGENT; IODINE 125;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTROCYTOMA; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RELAPSE; CANCER SURGERY; CHILD; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLIOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OLIGODENDROGLIOMA; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; SALVAGE THERAPY; SCHOOL CHILD; STEREOTACTIC BODY RADIATION THERAPY; SURVIVAL TIME; TUMOR GROWTH; TUMOR RECURRENCE; TUMOR VOLUME;

ADOLESCENT; ADULT; BRACHYTHERAPY; BRAIN NEOPLASMS; CHILD; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; GLIOMA; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; SALVAGE THERAPY; STEREOTAXIC TECHNIQUES; YOUNG ADULT;

EID: 80755125603     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/nor100     Document Type: Article

References (29)

1. Norden AD, Wen PY. Glioma therapy in adults. Neurologist. 2006;12(6):279-292. (Pubitemid 44813664)
2. Reardon DA, Wen PY. Therapeutic advances in the treatment of glioblastoma: rationale and potential role of targeted agents. Oncologist. 2006;11(2):152-164. (Pubitemid 43261762)
3. van den Bent MJ, Afra D, de Witte O, et al. Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet. 2005;366(9490):985-990. (Pubitemid 41323034)
4. Watanabe K, Sato K, Biernat W, et al. Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies. Clin Cancer Res. 1997;3(4):523-530. (Pubitemid 27211828)
5. Voges J, Treuer H, Schlegel W, Pastyr O, Sturm V. Interstitial irradiation of cerebral gliomas with stereotactically implanted iodine-125 seeds. Acta Neurochir Suppl (Wien). 1993;58:108-111.
6. Kreth FW, Faist M, Warnke PC, Rossner R, Volk B, Ostertag CB. Interstitial radiosurgery of low-grade gliomas. J Neurosurg. 1995;82(3):418-429.
7. Kreth FW, Faist M, Grau S, Ostertag CB. Interstitial 125I radiosurgery of supratentorial de novo WHO Grade 2 astrocytoma and oligoastrocytoma in adults: long-term results and prognostic factors. Cancer. 2006;106(6):1372-1381. (Pubitemid 43363917)
8. Kiebert GM, Curran D, Aaronson NK, et al. Quality of life after radiation therapy of cerebral low-grade gliomas of the adult: results of a randomised phase III trial on dose response (EORTC trial 22844). EORTC Radiotherapy Co-operative Group. Eur J Cancer. 1998;34(12):1902-1909. (Pubitemid 28535439)
9. Shaw E, Arusell R, Scheithauer B, et al. Prospective randomized trial of low-versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study. J Clin Oncol. 2002;20(9):2267-2276. (Pubitemid 34441653)
10. Bonita R, Beaglehole R. Recovery of motor function after stroke. Stroke. 1988;19(12):1497-1500. (Pubitemid 19005804)
11. Rankin J. Cerebral vascular accidents in patients over the age of 60. II. Prognosis. Scott Med J. 1957;2(5):200-215.
12. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19(5):604-607.
13. Macdonald DR, Cascino TL, Schold SC, Jr, Cairncross JG. Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol. 1990;8(7):1277-1280. (Pubitemid 20195640)
14. Wurker M, Herholz K, Voges J, et al. Glucose consumption and methionine uptake in low-grade gliomas after iodine-125 brachytherapy. Eur J Nucl Med. 1996;23(5):583-586. (Pubitemid 26140591)
15. Treuer H, Kocher M, Hoevels M, et al. Impact of target point deviations on control and complication probabilities in stereotactic radiosurgery of AVMs and metastases. Radiother Oncol. 2006;81(1):25-32. (Pubitemid 44540231)
16. Karim AB, Maat B, Hatlevoll R, et al. A randomized trial ondose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844. Int J Radiat Oncol Biol Phys. 1996;36(3):549-556. (Pubitemid 26404297)
17. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
18. Cox DR. Regression model and life-tables. J Roy Stat Soc Ser B. 1972;34:187-220.
19. Lawless JF, Singhal K. Efficient screening of non-normal regression models. Biometrics. 1978;34:318-327. (Pubitemid 8360278)
20. Schnell O, Scholler K, Ruge M, Siefert A, Tonn JC, Kreth FW. Surgical resection plus stereotactic 125I brachytherapy in adult patients with eloquently located supratentorial WHO grade II glioma - feasibility and outcome of a combined local treatment concept. J Neurol. 2008;255(10):1495-1502.
21. Pignatti F, van den Bent M, Curran D, et al. Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol. 2002;20(8):2076-2084. (Pubitemid 34408798)
22. Ostertag CB, Weigel K, Warnke P, Lombeck G, Kleihues P. Sequential morphological changes in the dog brain after interstitial iodine-125 irradiation. Neurosurgery. 1983;13(5):523-528. (Pubitemid 14231941)
23. Groothuis DR, Wright DC, Ostertag CB. The effect of 125I interstitial radiotherapy on blood-brain barrier function in normal canine brain. J Neurosurg. 1987;67(6):895-902. (Pubitemid 18005537)
24. van Veelen ML, Avezaat CJ, Kros JM, van Putten W, Vecht C. Supratentorial low grade astrocytoma: prognostic factors, dedifferentiation, and the issue of early versus late surgery. J Neurol Neurosurg Psychiatry. 1998;64(5):581-587. (Pubitemid 28204142)
25. Smith JS, Chang EF, Lamborn KR, et al. Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. J Clin Oncol. 2008;26(8):1338-1345.
26. Claus EB, Horlacher A, Hsu L, et al. Survival rates in patients with lowgrade glioma after intraoperative magnetic resonance image guidance. Cancer. 2005;103(6):1227-1233. (Pubitemid 40328094)
27. Sanai N, Polley MY, Berger MS. Insular glioma resection: assessment of patient morbidity, survival, and tumor progression. J Neurosurg. 2010;112(1):1-9.
28. Ohgaki H. Genetic pathways to glioblastomas. Neuropathology. 2005;25(1):1-7. (Pubitemid 40477707)
29. Sanai N, Berger MS. Glioma extent of resection and its impact on patient outcome. Neurosurgery. 2008;62(4):753-764; discussion 264-756.